Skip to main
XRAY
XRAY logo

DENTSPLY SIRONA (XRAY) Stock Forecast & Price Target

DENTSPLY SIRONA (XRAY) Analyst Ratings

Based on 12 analyst ratings
Hold
Strong Buy 17%
Buy 17%
Hold 67%
Sell 0%
Strong Sell 0%

Bulls say

Dentsply Sirona has demonstrated solid sales performance, particularly in Europe, where reported sales grew by 9.9% and 2.6% on a constant currency basis. Additionally, the Wellspect Healthcare segment has been a significant growth driver, achieving a reported revenue increase of 15.6%, highlighting the company's ability to generate strong volumes across various sales regions. Furthermore, expectations for improved operating expenses as a percentage of revenue suggest a positive outlook for operational efficiency going forward, reinforcing the company's strong market position in the dental equipment and supplies industry.

Bears say

Dentsply Sirona projects a decline in constant currency sales, now estimating a reduction of 4% to 5% compared to an earlier forecast of 2% to 4%. The company's gross margin is expected to decrease by 160 basis points in Q3/25 relative to the same period in 2024, indicating ongoing pressure on profitability, although a slight improvement is anticipated for Q4. Additionally, the company's orthodontics and implants segment is projected to decline by 15%, primarily due to significant headwinds from the Byte business shutdown, contributing to an overall downward adjustment in expected earnings per share and adjusted EBITDA margin for FY/25.

DENTSPLY SIRONA (XRAY) has been analyzed by 12 analysts, with a consensus rating of Hold. 17% of analysts recommend a Strong Buy, 17% recommend Buy, 67% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of DENTSPLY SIRONA and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About DENTSPLY SIRONA (XRAY) Forecast

Analysts have given DENTSPLY SIRONA (XRAY) a Hold based on their latest research and market trends.

According to 12 analysts, DENTSPLY SIRONA (XRAY) has a Hold consensus rating as of Nov 26, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $17.58, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $17.58, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

DENTSPLY SIRONA (XRAY)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.